Pirfenidone demonstrated pleiotropic antiinflammatory effects in various experimental and clinical settings. The aim of this study was to assess the impact of previous treatment with pirfenidone on short-term outcomes after single lung transplantation (SLTx). Therefore, patients with idiopathic pulmonary fibrosis (IPF) who were undergoing SLTx were screened retrospectively for previous use of pirfenidone and compared to respective controls. Baseline parameters and short-term outcomes were recorded and analyzed. In total, 17 patients with pirfenidone were compared with 26 patients without antifibrotic treatment. Baseline characteristics and severity of disease did not differ between groups. Use of pirfenidone did not increase blood loss, wound-healing, or anastomotic complications. Severity of primary graft dysfunction at 72 hours was less (0.3 ± 0.6 vs 1.4 ± 1.3, P = .002), and length of mechanical ventilation (37.5 ± 34.8 vs 118.5 ± 151.0 hours, P = .016) and intensive care unit (ICU) stay (6.6 ± 7.1 vs 15.6 ± 20.3, P = .089) were shorter in patients with pirfenidone treatment. An independent beneficial effect of pirfenidone was confirmed by regression analysis while controlling for confounding variables (P = .016). Finally, incidence of acute cellular rejections within the first 30 days after SLTx was lower in patients with previous pirfenidone treatment (0.0% vs 19.2%; P = .040). Our data suggest a beneficial role of previous use of pirfenidone in patients with IPF who were undergoing SLTx.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajt.15378 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis.
Adv Sci (Weinh)
December 2024
Lung Repair & Regeneration Department, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach, Germany.
Idiopathic pulmonary fibrosis (IPF) is a lethal disease with substantial unmet medical needs. While aberrant epithelial remodeling is a key factor in IPF progression, the molecular mechanisms behind this process remain elusive. Harnessing a 3D patient-derived organoid model and multi-omics approach, the first inventory of the connection between metabolic alteration, chromatin accessibility, and transcriptional regulation in IPF aberrant epithelial remodeling is provided.
View Article and Find Full Text PDFPerioperative inpatient falls for anterior cervical discectomy and fusion patients are on the rise: risk factors associated with this "never event".
Spine J
December 2024
Department of Orthopaedics & Rehabilitation, Yale School of Medicine, 47 College St, New Haven, CT, USA. Electronic address:
Article Synopsis
- The study analyzes inpatient falls (IPFs) in patients who underwent anterior cervical discectomy and fusion (ACDF), noting that these falls should be preventable and are classified as "never events".
- No prior research has focused on the occurrence and trends of these falls in ACDF patients, prompting this investigation from 2010 to Q3 2022.
- Results show that out of 294,165 patients, 5,548 experienced falls, with the incidence of falls increasing over the years, highlighting the need for better preventive measures.
Exploring Smad5: a review to pave the way for a deeper understanding of the pathobiology of common respiratory diseases.
Mol Med
November 2024
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Article Synopsis
- Smad5 is a key protein in the bone morphogenetic protein (BMP) signaling pathway, influencing various functions in respiratory diseases while its individual roles have been underexplored.
- This review focuses on Smad5's gene characteristics, protein structure, localization, and involvement in diseases like COPD, asthma, PAH, lung cancer, and IPF—with emphasis on cell behavior like proliferation and apoptosis.
- The paper highlights Smad5's unique nuclear-cytoplasmic shuttling abilities, which may be significant in understanding its role in the development and progression of respiratory diseases.
The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19.
Cell Commun Signal
November 2024
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Despite the tremendous advancements in the knowledge of the pathophysiology and clinical aspects of SARS-CoV-2 infection, still many issues remain unanswered, especially in the long-term effects. Mounting evidence suggests that pulmonary fibrosis (PF) is one of the most severe complications associated with COVID-19. Therefore, understanding the molecular mechanisms behind its development is helpful to develop successful therapeutic strategies.
View Article and Find Full Text PDFInhalation exposure to chemicals, microbiota dysbiosis and adverse effects on humans.
Sci Total Environ
December 2024
School of Life Sciences and Allied Health Professions, Kamuzu University of Health Sciences, Blantyre Campus, Mahatma Gandhi Road, Blantyre 312224, Malawi.
Article Synopsis
- Disruption of the lung microbiota (LM) can mediate harmful effects from inhaled chemicals, influencing respiratory health and linked to conditions like asthma and lung cancer.
- Factors such as air pollution and cigarette smoke can cause LM dysbiosis, affecting the gut microbiota and potentially leading to diseases through interactions like the Gut-Lung axis.
- More rigorous research is needed to establish causal links between LM dysbiosis and respiratory diseases, as current findings are primarily associative, and advancing techniques for studying the lung microbiome can improve understanding of these connections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!